Skip to main content
. 2021 Jul 18;8(1):e000981. doi: 10.1136/bmjresp-2021-000981

Table 1.

Characteristics and prevalence of respiratory symptoms at study entry among women, men and all participants

Characteristics Women
n=545
Men
n=432
P value All
n=977
Age Mean (SD) in years 40.3 (12.0) 40.7 (11.4) 0.600 40.4 (11.7)
BMI mean (SD) 25.2 (4.5) 26.1 (3.4) <0.001 25.6 (4.1)
BMI category <0.001
 Underweight (BMI <20) 42 (7.7) 8 (1.9) 50 (5.1)
 Normal (20≤BMI<25) 266 (48.8) 175 (40.5) 441 (45.1)
 Overweight (25≤BMI<30) 145 (26.6) 183 (42.4) 328 (33.6)
 Obese (BMI≥30) 78 (14.3) 55 (12.7) 133 (13.6)
 BMI missing 14 (2.6) 11 (2.5) 25 (2.6)
Smoking habits 0.080
 Non-smoker 250 (45.9) 185 (42.8) 435 (44.5)
 Ex-smoker 139 (25.5) 138 (31.9) 277 (28.4)
 Current smoker 156 (28.6) 109 (25.2) 265 (27.1)
Any asthma medication use last 12 months 189 (34.7) 170 (39.4) 0.132 359 (36.7)
Inhaled corticosteroids use last 12 months 0.077
 As needed 13 (2.4) 22 (5.1) 35 (3.6)
 Most days of the week 46 (8.4) 35 (8.1) 81 (8.3)
Allergic rhinitis 192 (35.2) 147 (34) 0.695 339 (34.7)
Cohort 0.054
 I 92 (16.9) 79 (18.3) 171 (17.5)
 II 220 (40.4) 194 (44.9) 414 (42.4)
 III 46 (8.4) 37 (8.6) 83 (8.5)
 IV 56 (10.3) 52 (12) 108 (11.1)
 V 131 (24) 70 (16.2) 201 (20.6)
Recurrent wheeze 430 (78.9) 332 (76.9) 0.443 762 (78.0)
Dyspnoea 175 (32.1) 64 (14.8) <0.001 239 (24.5)
Longstanding cough 275 (50.5) 168 (38.9) <0.001 443 (45.3)
Productive cough 195 (35.8) 151 (35.0) 0.789 346 (35.4)
Number of symptoms <0.001
 None or one 206 (37.8) 216 (50.0) 422 (43.2)
 Two 157 (28.8) 110 (25.5) 267 (27.3)
 Three 127 (23.3) 87 (20.1) 214 (21.9)
 Four 55 (10.1) 19 (4.4) 74 (7.6)

Basic characteristics presented as mean (SD) with p values from t-test and n (%) with p values from χ2 test.

The number of symptom groups include recurrent wheeze, dyspnoea, longstanding cough and productive cough.